Collegium Pharmaceutical
COLL
120 hedge funds and large institutions have $580M invested in Collegium Pharmaceutical in 2018 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 40 increasing their positions, 48 reducing their positions, and 19 closing their positions.
275% more call options, than puts
Call options by funds: $1.2M | Put options by funds: $319K
18% more capital invested
Capital invested by funds: $492M → $580M (+$88.3M)
0.9% more ownership
Funds ownership: 100.74% → 101.64% (+0.9%)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
3% less funds holding
Funds holding: 124 → 120 (-4)
16% less first-time investments, than exits
New positions opened: 16 | Existing positions closed: 19
17% less repeat investments, than reductions
Existing positions increased: 40 | Existing positions reduced: 48
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$20M |
| 2 |
PA
Perceptive Advisors
New York
|
+$7.61M |
| 3 |
RHJA
Rice Hall James & Associates
San Diego,
California
|
+$6.27M |
| 4 |
UBS AM
Chicago,
Illinois
|
+$5.01M |
| 5 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
+$3.79M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
-$14.2M |
| 2 |
JGC
J. Goldman & Co
New York
|
-$8.81M |
| 3 |
Morgan Stanley
New York
|
-$8.16M |
| 4 |
MC
Maverick Capital
Dallas,
Texas
|
-$6.22M |
| 5 |
Two Sigma Investments
New York
|
-$3.37M |
COLL Hedge Fund Activity: Q4 2018 in Review
120 of the 4,489 institutional investors tracked by Wall St. Rank reported a position in Collegium Pharmaceutical (COLL) for Q4 2018, worth a combined $580M — up 18% from $492M a quarter earlier.
Sellers outnumbered buyers: 19 funds closed out of COLL and 16 opened new positions — a net loss of 3 holders — while 48 trimmed existing stakes and 40 added.
The largest buyer was Millennium Management, adding an estimated $20M. The largest seller was Sectoral Asset Management, cutting an estimated $14.2M.
- 120 institutional investors held Collegium Pharmaceutical (COLL) as of Q4 2018, down from 124 in Q3 2018.
- Funds reported $580M of Collegium Pharmaceutical stock for Q4 2018, up 18% quarter-over-quarter.
- 16 funds opened new Collegium Pharmaceutical positions in Q4 2018 and 19 closed out, a net change of -3 holders.
- The largest Collegium Pharmaceutical buyer in Q4 2018 was Millennium Management, an estimated $20M added.
- The largest Collegium Pharmaceutical seller in Q4 2018 was Sectoral Asset Management, an estimated $14.2M sold.
Based on aggregated 13F filings for Q4 2018.